- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.4%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH and its peers as on 21 August, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 23.27% | -0.4% | -0.88% | 1.43% | 9.85% | 19.12% | 24.15% | 19.25% | 26.46% | 15.04% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -4.52% | -0.31% | -1.01% | 0.61% | 3.5% | -6.77% | 8.04% | 14.28% | 16.92% | 14.11% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.66% | 0.07% | -0.07% | 0.97% | 5.68% | 1.7% | 11.14% | 10.16% | 14.05% | 12.13% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 2.72% | -0.03% | -1.43% | -1.99% | 0.11% | 4.99% | 15.77% | 18.42% | 20.37% | 15.3% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 6.52% | -0.2% | -0.21% | 0.6% | 0.22% | 12.28% | 17.88% | 12.65% | 20.63% | 15.66% |
| SBI MNC FUND - DIRECT PLAN -GROWTH | 18.11% | 0.04% | -0.2% | 4.14% | 10.45% | 16.1% | 9.01% | 9.91% | 15.57% | 12.21% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -12.62% | 2.71% | -8.64% | 0.65% | 68.71% | 20.05% | -4.78% | 40.03% | 43.86% | -2.89% |
Discrete returns (monthly)
| Month | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 2.61% | 0.63% | -2.82% | -3.5% | 6.36% | -3.54% | 5.89% | 4.65% | 8.07% | 4.5% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 19.11% | 12.63% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 98.31% | 0.05% (Arbitrage: 0.00%) | 0.00% | 0.00% | 1.64% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.72% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.46% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 5.17% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.07% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 4.98% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.74% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 4.58% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 4.04% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 3.86% |
| Aster DM Quality Care Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.65% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 2.96% |
| Jupiter Life Line Hospitals Ltd. | (INE682M01020) | Healthcare Services | 2.88% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 2.82% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.78% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.63% |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.44% |
| Aether Industries Ltd. | AETHER (INE0BWX01014) | Chemicals & Petrochemicals | 2.28% |
| Sudeep Pharma Ltd. | SUDEEPPHRM (INE0QPI01025) | Chemicals & Petrochemicals | 2.22% |
| Polymedicure Ltd. | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 2.02% |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 1.98% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.93% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 1.89% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.83% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 1.79% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 1.73% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 1.67% |
| Nephrocare Health Service Pvt. Ltd. | NEPHROPLUS (INE428V01029) | Healthcare Services | 1.20% |
| Dr. Lal Path labs Ltd. | LALPATHLAB (INE600L01024) | Healthcare Services | 1.06% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 1.03% |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 0.96% |
| Rainbow Children's Medicare Ltd. | RAINBOW (INE961O01016) | Healthcare Services | 0.85% |
| Healthcare Global Enterprises Ltd. | HCG (INE075I01017) | Healthcare Services | 0.73% |
| Gufic Biosciences Ltd. | GUFICBIO (INE742B01025) | Pharmaceuticals & Biotechnology | 0.36% |
Debt
| Name | Rating | Weight % |
|---|---|---|
| 364 DAY T-BILL 19.11.26 | Sovereign | 0.05% |
Portfolio data is as on date 31 July, 2026
NAV history
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 21 August, 2026 | 597.0514 | -0.4% |
| 20 August, 2026 | 599.4733 | -0.21% |
| 19 August, 2026 | 600.7214 | -0.43% |
| 18 August, 2026 | 603.3454 | 0.82% |
| 17 August, 2026 | 598.4205 | -0.65% |
| 14 August, 2026 | 602.3331 | 0.14% |
| 13 August, 2026 | 601.4736 | -0.24% |
| 12 August, 2026 | 602.9426 | -0.83% |
| 11 August, 2026 | 607.9991 | 0.63% |
| 10 August, 2026 | 604.1639 | 0.66% |
| 7 August, 2026 | 600.1975 | 0.19% |
| 6 August, 2026 | 599.0570 | 0.18% |
| 5 August, 2026 | 597.9557 | 0.09% |
| 4 August, 2026 | 597.4461 | 0.3% |
| 3 August, 2026 | 595.6658 | 0.29% |
| 31 July, 2026 | 593.9416 | 0.39% |
| 30 July, 2026 | 591.6347 | -0.24% |
| 29 July, 2026 | 593.0834 | 1.29% |
| 28 July, 2026 | 585.5363 | 0.01% |
| 27 July, 2026 | 585.4834 | 1.84% |
| 24 July, 2026 | 574.8814 | -0.4% |
| 23 July, 2026 | 577.1783 | -0.91% |
| 22 July, 2026 | 582.4732 | -1.05% |
| 21 July, 2026 | 588.6244 | 0.38% |
| 20 July, 2026 | 586.4105 | 0.98% |
| 17 July, 2026 | 580.7036 | -0.87% |
| 16 July, 2026 | 585.8266 | 0.32% |
| 15 July, 2026 | 583.9614 | 0.63% |
| 14 July, 2026 | 580.2884 | 0.53% |
| 13 July, 2026 | 577.2386 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH is 597.0514 as on 21 August, 2026.What are YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 23.27% as on 21 August, 2026.What are 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 19.12% as on 21 August, 2026.What are 3 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 3 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 24.15% as on 21 August, 2026.What are 5 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 5 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 19.25% as on 21 August, 2026.What are 10 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 10 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 19.25% as on 21 August, 2026.